Liu YH - Search Results

1

Oncogenic activation of the STAT3 pathway drives PD-L1 expression in natural killer/T-cell lymphoma.

Song TL, Nairismägi ML, Laurensia Y, Lim JQ, Tan J, Li ZM, Pang WL, Kizhakeyil A, Wijaya GC, Huang DC, Nagarajan S, Chia BK, Cheah D, Liu YH, Zhang F, Rao HL, Tang T, Wong EK, Bei JX, Iqbal J, Grigoropoulos NF, Ng SB, Chng WJ, Teh BT, Tan SY, Verma NK, Fan H, Lim ST, Ong CK. Song TL, et al. Among authors: liu yh. Blood. 2018 Sep 13;132(11):1146-1158. doi: 10.1182/blood-2018-01-829424. Epub 2018 Jul 27. Blood. 2018. PMID: 30054295 Free PMC article.

2

[Clinicopathologic significance of bcl-6 gene rearrangement and expression in three molecular subgroups of diffuse large B-cell lymphoma].

Xu FP, Liu YH, Luo XL, Zhuang HG, Li L, Luo DL, Xu J, Zhang F, Zhang MH, Du X, Li WY. Xu FP, et al. Among authors: liu yh. Zhonghua Bing Li Xue Za Zhi. 2008 Jun;37(6):371-6. Zhonghua Bing Li Xue Za Zhi. 2008. PMID: 19031715 Chinese.

3

[Clinicopathologic study of pulmonary adenocarcinoma with features of bronchioloalveolar carcinoma].

Luo DL, Liu YH, Zhuang HG, Liao RQ, Luo XL, Xu FP, Zhang F. Luo DL, et al. Among authors: liu yh. Zhonghua Bing Li Xue Za Zhi. 2008 Nov;37(11):737-42. Zhonghua Bing Li Xue Za Zhi. 2008. PMID: 19094707 Chinese.

4

[Extranodal nasal type NK/T-cell lymphoma: clinicopathologic and prognostic study of 55 cases].

Li L, Liu YH, Zhuang HG, Luo XL, Zhang F, Xu FP, Luo DL. Li L, et al. Among authors: liu yh. Zhonghua Bing Li Xue Za Zhi. 2009 Apr;38(4):237-42. Zhonghua Bing Li Xue Za Zhi. 2009. PMID: 19575894 Chinese.

5

Justification of the change from 10% to 30% for the immunohistochemical HER2 Scoring criterion in breast cancer.

Liu YH, Xu FP, Rao JY, Zhuang HG, Luo XL, Li L, Luo DL, Zhang F, Xu J. Liu YH, et al. Am J Clin Pathol. 2009 Jul;132(1):74-9. doi: 10.1309/AJCPG3LCVKPNFJ6R. Am J Clin Pathol. 2009. PMID: 19864236

6

[Clinicopathologic study of 963 cases of mature T-cell and natural killer/T-cell lymphoma with respect to 2008 WHO classification of lymphoid neoplasms].

Liang Q, Ye ZY, Su ZL, Lin HL, Shao CK, Lin SX, Rao HL, Mei KY, Zhao T, Liu YH, Luo DL, Zhu MG, Chen SH, Lin TY. Liang Q, et al. Among authors: liu yh. Zhonghua Bing Li Xue Za Zhi. 2010 May;39(5):291-5. Zhonghua Bing Li Xue Za Zhi. 2010. PMID: 20654150 Chinese.

7

EZH2 protein: a promising immunomarker for the detection of hepatocellular carcinomas in liver needle biopsies.

Cai MY, Tong ZT, Zheng F, Liao YJ, Wang Y, Rao HL, Chen YC, Wu QL, Liu YH, Guan XY, Lin MC, Zeng YX, Kung HF, Xie D. Cai MY, et al. Among authors: liu yh. Gut. 2011 Jul;60(7):967-76. doi: 10.1136/gut.2010.231993. Epub 2011 Feb 17. Gut. 2011. PMID: 21330577 Free article.

8

[Immunophenotypes and prognosis of diffuse large B-cell lymphoma: a study of 500 cases].

Luo DL, Liu YH, Zhuang HG, Li L, Xu FP, Zhang F, Luo XL, Xu J. Luo DL, et al. Among authors: liu yh. Zhonghua Bing Li Xue Za Zhi. 2011 Apr;40(4):235-9. Zhonghua Bing Li Xue Za Zhi. 2011. PMID: 21615996 Chinese.

9

[Signaling pathways in pathogenesis of diffuse large B-cell lymphoma].

Zhang F, Xu FP, Liu YH, Zhuang HG. Zhang F, et al. Among authors: liu yh. Zhonghua Bing Li Xue Za Zhi. 2011 Apr;40(4):282-5. Zhonghua Bing Li Xue Za Zhi. 2011. PMID: 21616012 Review. Chinese. No abstract available.

10

[Association of HER2 protein expression with clinicopathologic features and prognosis in Chinese patients with gastric carcinoma].

Wu HM, Liu YH, Lin F, Xu FP, Luo DL, Zhang F, Zhuang HG, Luo XL, Wu WL, Lin XT. Wu HM, et al. Among authors: liu yh. Zhonghua Bing Li Xue Za Zhi. 2011 May;40(5):296-9. Zhonghua Bing Li Xue Za Zhi. 2011. PMID: 21756821 Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,548 results

Search Page

Filters